The WHOs china chief has termed the conditional approval granted by the global health body to china first COVID-19 Vaccine Sino pharms as a milestone achievement which will create an opening to significantly increase the global supply of vaccines. This decision announced on Friday by the World Health Organisation in Geneva to grant Emergency use listing to a COVID-19 vaccine manufactured in China represents a milestone achievement, said in a statement her on Saturday. On vaccine has received EUL, but we know that there are over fifteen additional COVID-19 vaccines in advanced development in China.
Today’s milestone achievement should spur other manufacturers to pursue this route and add to the global vaccine arsenal. In a Big relief for China the WHO on Friday finally granted the conditional approval to its Sino pharm COVID-19 vaccine from a non-western country to get the recognition. The WHO listing the expected to help Chine step up its vaccine diplomacy amid the surge in coronavirus vaccines in several countries. Though china has been supplying vaccines to various countries hesitated using the vaccine as it has not secured recognition from the WHO. China was eagerly awaiting the global health body’s nod for it to aggressively push the vaccine among different countries.